Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia


Balcioglu Y. H. , Kalelioglu T., Durak N., Karamustafalioglu N., Genc A., Emul M.

29th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Vienna, Austria, 17 - 20 September 2016, vol.26 identifier